Search Results

What’s Next for Interventional Glaucoma?

A panel of experts discusses how ophthalmologists and optometrists explore evolving mindsets, communication, and operational changes.

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Mitch Ibach, OD, FAAO; and Savak “Sev” Teymoorian, MD, MBA

The Emergence of Breakthrough Procedural Pharmaceutical Therapies

Mark Gallardo; Courtney Bovee; and Savak Teymoorian

Educating on Early Intervention: Describing the Benefits of Interventional Glaucoma

Adopting the interventional glaucoma mindset necessitates a shift in thinking, including how patients are educated.

Savak Teymoorian, MD, MBA, and J. Morgan Micheletti, MD

Cover Focus

Drug Delivery: Pearls and Projections

Contributors comment on the present use and future potential of this treatment approach.

Malik Y. Kahook, MD; Jason Bacharach, MD; Courtney Bovee, MD; Savak Teymoorian, MD, MBA; John P. Berdahl, MD; Constance Okeke, MD, MSCE; and Steven R. Sarkisian Jr, MD

Cover Focus

Drug Delivery: Real-World Updates and Future Outlook

A roundtable discussion of solutions on the market and in the pipeline.

Richard A. Lewis, MD; E. Randy Craven, MD; L. Jay Katz, MD; James Katz, MD; and Savak Teymoorian, MD, MBA

Cover Focus

Sustained Drug Delivery in Practice

Pointers for navigating patient education, practice considerations, insurance coverage, and more.

Savak Teymoorian, MD, MBA

Patient Views

Visiting the Glaucoma Clinic in the Time of COVID-19

The patient perspective on the changes made and updates still desired.

Richie Kahn, MPH

Practice Pointers

Company Culture: The Secret Sauce for Success

A successful company culture can provide a strategic advantage for practices looking to stand apart from the competition.

Savak Teymoorian, MD, MBA